Log in to your Inderes Free account to see all free content on this page.
Corline Biomedical
9.68
SEK
+2.11 %
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+2.11%
+10.25%
+29.76%
+7.56%
-24.08%
-37.75%
-33.47%
-32.05%
-2.14%
Corline Biomedical operates in the pharmaceutical industry. The company develops with the substance heparin and has developed a portfolio of drug candidates for use in connection with organ and cell transplantation. The drug candidates are based on the same basic technology as the medical technology products. Corline Biomedical operates on the Nordic market and is headquartered in Uppsala.
Read moreMarket cap
237.07M SEK
Turnover
387.69K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
17.2.
2025
Annual report '24
8.5.
2025
Interim report Q1'25
26.8.
2025
Interim report Q2'25
ShowingAll content types
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio